Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs STMicroelectronics NV (STM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs STMicroelectronics NV — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while STMicroelectronics NV trades at $44.87 (market cap $43.15B). The key difference: STMicroelectronics NV is the larger of the two by market cap, and STMicroelectronics NV pays the higher dividend (0.77%). Which is the better fit depends on your goals.
| GEHC | STM | |
|---|---|---|
Market Cap | $30.93B | $43.15B |
Volume | 5,033,451 | 14,115,128 |
Sector | Health | Technology |
52-Week High | $88.16 | $79.91 |
52-Week Low | $59.48 | $21.20 |
Enterprise Value | $39.39B | $40.67B |
Dividend Yield | 0.23% | 0.77% |
Typical Hold Time | — | 65 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
STM trades at $49.57, down 1.8% on the day, with a bearish technical signal but strong analyst support. The company reported mixed Q2 2026 earnings, beating expectations with $0.31 EPS versus $0.26 expected, while revenue trends show recovery with 26% year-on-year growth in Q2. Valuation metrics appear elevated with a P/E of 94.59, but the company maintains solid cash flow and a strong balance sheet with $6.18 billion in cash.
STM faces near-term profitability challenges with negative net income margins, but strong AI data-center revenue growth projections to exceed $2 billion by 2027 provide upside potential. Key risks include execution on margin improvement and competitive pressures in semiconductor markets. Analyst consensus remains bullish with a $77.31 price target representing 56% upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About STMicroelectronics NV
A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconductors in France formed STMicroelectronics in 1987. STMicro is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. STMicro is an especially prominent chip supplier into the industrial and automotive industries.
Read more on STM →
